Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (2)
Blood Cancer Journal (2)
Cell Death & Disease (1)
Nature (1)
npj Precision Oncology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (6)
Correspondence (1)

Subject Check one or more subjects to show results from those subjects only.

Biological techniques
Cancer
Cell biology
Developmental biology
Diseases
Health care
Immunology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–7 of 7 results

Advanced filters: Author: Taghi Manshouri Clear advanced filters

GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes

Taghi Manshouri
Ivo Veletic
Zeev Estrov
ResearchOpen Access20 May 2022
Cell Death & Disease

Volume: 13, P: 1-14
Multimodal spatial proteomic profiling in acute myeloid leukemia

Christopher P. Ly
Ivo Veletic
Hussein A. Abbas
ResearchOpen Access20 May 2025
npj Precision Oncology

Volume: 9, P: 1-13
Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy

Chronic exposure to JAK2 inhibitors leads to reactivation of downstream signalling through the formation of heterodimers between JAK2 and other JAK kinases in myeloproliferative neoplasms, which can be overcome with Hsp90 inhibitors.

Priya Koppikar
Neha Bhagwat
Ross L. Levine
Research22 Jul 2012
Nature

Volume: 489, P: 155-159
CLL cell-derived exosomes alter the immune and hematopoietic systems

Ivo Veletic
David M. Harris
Zeev Estrov
Research04 Apr 2025
Leukemia

Volume: 39, P: 1380-1394
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells

Warren Fiskus
Christopher P. Mill
Kapil N. Bhalla
ResearchOpen Access20 May 2021
Blood Cancer Journal

Volume: 11, P: 1-16
Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AML

Dyana T. Saenz
Warren Fiskus
Kapil N. Bhalla
Research21 Dec 2018
Leukemia

Volume: 33, P: 1373-1386
Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells

Warren Fiskus
Taghi Manshouri
Kapil N. Bhalla
CorrespondenceOpen Access31 Jan 2022
Blood Cancer Journal

Volume: 12, P: 1-5